EntryPoint Capital’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
VCM
VPM
N
EntryPoint Capital's ADMA Position: Q1 2026 in Review
EntryPoint Capital opened a new position in ADMA Biologics (ADMA) in Q1 2026: 83,961 shares worth $756K. The stake represents 0.22% of the portfolio and ranks #113 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in ADMA as recently as Q3 2024.
EntryPoint Capital first reported a position in ADMA in Q1 2024 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.
- EntryPoint Capital held 83,961 shares of ADMA Biologics worth $756K as of Q1 2026.
- ADMA Biologics was a new EntryPoint Capital position in Q1 2026.
- ADMA Biologics made up 0.22% of EntryPoint Capital's portfolio in Q1 2026, its #113 holding.
- EntryPoint Capital first reported a position in ADMA Biologics in Q1 2024 and has held it in 4 quarters since.
- 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.
Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.